Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cybin Inc (CLXPF)

Cybin Inc (CLXPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLXPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9500 +47.37%
on 03/30/21
1.5400 -9.09%
on 04/14/21
+0.0261 (+1.90%)
since 03/16/21
3-Month
0.9500 +47.37%
on 03/30/21
2.2350 -37.36%
on 01/21/21
-0.5500 (-28.21%)
since 01/15/21

Most Recent Stories

More News
Psychedelics Could Play a Crucial Role in Your Mental Health Treatment

Psychedelics have become the new mental health buzzword. With clinical trials supporting psychedelic ...

CLXPF : 1.4000 (-3.45%)
MMEDF : 2.4300 (-0.82%)
ENBI.CN : 0.490 (-5.77%)
ENTBF : 0.3799 (-13.56%)
NUMI.VN : 0.900 (-2.17%)
LKYSF : 0.7204 (-1.32%)
PSYCF : 0.2006 (-2.86%)
PSYC.CN : 0.250 (-3.85%)
Industry Leaders Look To Artificial Intelligence To Drive Advancements In Mental Healthcare

Prominent mental healthcare conditions including anxiety, depression, and PTSD have historically required ...

MCURF : 0.3204 (-0.53%)
MMEDF : 2.4300 (-0.82%)
NUMI.VN : 0.900 (-2.17%)
LKYSF : 0.7204 (-1.32%)
FTRP.CN : 6.020 (+2.03%)
FTRPF : 4.8218 (+3.37%)
CLXPF : 1.4000 (-3.45%)
MCUR.CN : 0.380 (-7.32%)
Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced plans to advance the pre-clinical work for its orally...

CLXPF : 1.4000 (-3.45%)
Mainstream Mental Health is Quickly Embracing Psychedelic Drug Therapies

These days, we can make a very strong case for mind-altering treatments for mental health. Not ...

SEEL : 5.26 (-0.38%)
CLXPF : 1.4000 (-3.45%)
MMEDF : 2.4300 (-0.82%)
TRYP.CN : 0.630 (-7.35%)
SILO.CN : 0.210 (unch)
Music May Play a Critical Role in Psychedelic Therapy Sessions

When it comes to psychedelic therapy, music may heighten the benefit. For example, studies have shown ...

CLXPF : 1.4000 (-3.45%)
MMEDF : 2.4300 (-0.82%)
NUMI.VN : 0.900 (-2.17%)
LKYSF : 0.7204 (-1.32%)
FTRPF : 4.8218 (+3.37%)
NMDBF : 0.1679 (-6.72%)
FTRP.CN : 6.020 (+2.03%)
NEON.CN : 0.210 (-6.67%)
With US FDA Support and Breakthroughs, Psilocybin a Step Closer to Legalization

With support from the US FDA and several clinical studies, psilocybin is emerging as a way to help ...

CMPS : 34.35 (+0.94%)
CLXPF : 1.4000 (-3.45%)
MMEDF : 2.4300 (-0.82%)
PRXTF : 0.3120 (+2.16%)
PSYG.CN : 0.310 (-10.14%)
PULL.CN : 0.395 (+1.28%)
Why Mainstream Mental-Health Care is Embracing Psilocybin - Alternative Active Substances

, /PRNewswire/ -- Psychedelic healing may sound like a fad from the Woodstock era, but it's a field of study that's gaining traction in the medical community as an effective treatment option for a growing...

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
MMEDF : 2.4300 (-0.82%)
LKYSF : 0.7204 (-1.32%)
NUMI.VN : 0.900 (-2.17%)
CMPS : 34.35 (+0.94%)
CLXPF : 1.4000 (-3.45%)
Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced key senior management changes to lead the buildout...

CLXPF : 1.4000 (-3.45%)
Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

USA News Group – Expanding way beyond just hunting for the perfect truffle, rising interest ...

VEGGF : 0.0680 (+6.42%)
CLXPF : 1.4000 (-3.45%)
TRUFF : 0.2279 (+2.01%)
TRIP.CN : 0.285 (+1.79%)
MYCOF : 0.2749 (+1.81%)
MYCO.CN : 0.400 (-6.98%)
DCNPF : 0.2171 (-1.36%)
PSYC.CN : 0.250 (-3.85%)
PLNT.CN : 0.085 (+6.25%)
PULL.CN : 0.395 (+1.28%)
Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

, /PRNewswire/ --    -  Expanding way beyond just hunting for the perfect truffle, rising interest in the "" of mycology is creating gains across the , with a wave of new products to help us under...

PSYCF : 0.2006 (-2.86%)
PULL.CN : 0.395 (+1.28%)
PRXTF : 0.3120 (+2.16%)
CLXPF : 1.4000 (-3.45%)
TRUFF : 0.2279 (+2.01%)
TRIP.CN : 0.285 (+1.79%)
MYCOF : 0.2749 (+1.81%)
MYCO.CN : 0.400 (-6.98%)
PSYC.CN : 0.250 (-3.85%)

Key Turning Points

3rd Resistance Point 1.6833
2nd Resistance Point 1.5867
1st Resistance Point 1.4933
Last Price 1.4000
1st Support Level 1.3033
2nd Support Level 1.2067
3rd Support Level 1.1133

See More

52-Week High 2.2350
Fibonacci 61.8% 1.5699
Last Price 1.4000
Fibonacci 50% 1.3644
Fibonacci 38.2% 1.1589
52-Week Low 0.4938

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar